SOD1 and amyotrophic lateral sclerosis: The activation of the AA pathway has been previously reported in the spinal cord of SOD1 mice at early disease stages [64], whilst phospholipase A2, which catalyses the conversion of AA, has also been found upregulated in human ALS patients [83], and its inhibition seems to be beneficial in SOD1G93A mice [84].